A Phase 2, Randomized, Placebo Controlled, Dose Ranging Study of Oral JNJ 77242113 for the Treatment of Moderate to Severe Plaque Psoriasis

Efficacy of Overall and Scalp Psoriasis Responses From FRONTIER 1

DOWNLOAD PUBLICATION